Spasticity in Focus, Expert Conversations in PM&R: Coding and Billing
Description

Description

This webinar will highlight best practices for coding spasticity management procedures, selecting appropriate ICD-10 codes that meet medical necessity criteria, and navigating new policies taking effect January 1 that may impact your clinical practice. 

 

Learning Objectives

By the end of this session, participants will be able to:
  • Apply best practices for accurate billing and coding of spasticity management procedures.
  • Identify appropriate ICD-10 diagnosis codes that support medical necessity and coverage for spasticity management services.
  • Describe upcoming policy changes taking effect January 1 and assess their potential implications for clinical practice and reimbursement.

Principle Faculty

Zachary Bohart
Lauren Shapiro
Mary Beth Russel
Clarice Sinn

AAPM&R Medical Education Committee
Rachel Brakke Holman, MD - Nothing to Disclose

Sarah M. Eickmeyer, MD - Nothing to Disclose
Chelsea D. Frost, MD, MS - Nothing to Disclose
David J. Haustein, MBA,MD,MBA: PM Consulting, Ownership or Partnership; Expert Medical Consulting, Ownership or Partnership; Greene County Medical Society Executive Council, Non-remunerative Positions of Influence; Missouri State Medical Foundation Board, Non-remunerative Positions of Influence; Vice President of the Missouri State Medical Society, Non-remunerative Positions of Influence
Sarah K. Hwang, MD - Nothing to Disclose
Ravi E. Kasi, MD - Nothing to Disclose
Caroline Pupke, DO - Nothing to Disclose
Monica E. Rho, MD - Nothing to Disclose
McCasey R. Smith, MD - Nothing to Disclose
Jennifer A. Soo Hoo, MD - Nothing to Disclose
Brionn K. Tonkin, MD - Nothing to Disclose
Stephanie Tow, MD: Nothing to Disclose
Justin L. Weppner, DO - Nothing to Disclose
Alexandra G. Wolfe, DO - Nothing to Disclose

FDA Disclosures
Any faculty member for this activity who intends to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved, will verbally disclose the FDA’s classification at the beginning of their presentation or demonstration.  

Summary
Availability:
Registration Required
Location:
Online Meeting
Date / Time:
Dec 02, 2026 6:00 PM - 7:00 PM CT
Cost:
FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By